Biotechnology · Baltimore, MD · Privately Held (backing)
Developer of a red blood cell substitute designed to support oxygen delivery in trauma care settings. KaloCyte is based in Baltimore, MD. It was valued at $24.7 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $5.7 million across 1 recorded round; the latest was an accelerator round in Jan 2020.
PMV mark · valuation
$24.7M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$5.7M
Last round
Accelerator/Incubator
Jan 2020
Team — not yet on record
No current team members for KaloCyte are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of KaloCyte with a free account
·The complete investor list: 21 names
·Watch KaloCyte: the Monday email on marks, rounds and moves
